FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, genetic engineering and virology. Described is a chimeric protein comprising an L2-epitope of a human papillomavirus (HPV) type-16 inserted in a loop region of a human papillomavirus type-16 L1 protein; and a capsid which is an aggregate of the chimeric protein. The loop region to which the L2-epitope is to be inserted is located between an amino acid residue at position 430 and an amino acid residue at position 433. The L2-epitope has an amino acid sequence represented by any one of the following formulae: LYKTCKQAGTCPPDIIPKVEG (18-38 L2-epitope); GGLGIGTGSGTGGRTGYIPL (56-75 L2-epitope); and DPVGPLDPSIVSLVEESSFI (96-115 L2-epitope).
EFFECT: invention can be used to obtain a vaccine against human papillomavirus.
18 cl, 7 dwg, 5 tbl, 3 ex
Title |
Year |
Author |
Number |
VACCINE COMPOSITION APPLICABLE IN HPV AND HEPATITIS VIRUS INFECTIONS, AND METHOD FOR PREPARING IT |
2009 |
- Ehlla Krishna Murtkhi
- Sumatkhi Kandasvami
|
RU2509570C2 |
SEROLOGICAL TEST FOR THERAPEUTIC CONTROL OF HPV16-POSITIVE CARCINOMA |
2017 |
|
RU2757629C2 |
HPV CHIMERIC PARTICLE |
2012 |
- Rybitski Edvard Piter
- Khittserot Inga Izabel
|
RU2642287C2 |
IMPROVED IMMUNOGENICITY OF L2 HPV PEPTIDE |
2017 |
- Bolchi, Andzhelo
- Myuller, Martin
- Ottonello, Simone
- Pujyanfard, Somaje
- Spanoli, Gloriya
|
RU2743016C2 |
RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMA VIRUS EPITOPES, PROTEIN EMBEDDED ADENYLATECYCLASE OR ITS FRAGMENT, ITS THERAPEUTIC APPLICATION |
2005 |
- Preville Khav'Er-Ehdmond-Ehduard
- Leklerk Klod
- Ladant Daniel
- Timmerman Benedikt
|
RU2441022C2 |
APPLICATION OF SKELETON OF NOCARDIA RUBRA CELL WALL FOR OBTAINING MEDICATION AGAINST HUMAN PAPILLOMA VIRUS (HPV) |
2005 |
- Chzhan Tseh
- Chzhan I
- Khun Sjaomin
- Chzhan Goin
- Chzhao Tszjan'
|
RU2394586C2 |
PAPILLOMA VIRAL VACCINES |
1995 |
- Jansen Katrin U.
- Kuk Iii Dzhejms K.
- Dzhordzh Kh'Ju A.
- Khofmann Katrin Dzh.
- Dzhojs Dzhozef G.
- Lekhman Ehrnest Dejl
- Markus Genri Z.
- Rosolovskij Mark
- Shul'Ts Loren D.
|
RU2206608C2 |
CONJUGATE OF ANGIOTENSIN PEPTIDE COMPONENT WITH CARRIER, VACCINE COMPOSITION, METHOD OF ANIMAL IMMUNISATION AND METHOD OF TREATMENT OR PREVENTION OF PHYSICAL DISORDER RELATED TO ANGIOTENSIN SYSTEM ACTIVATED BY RENIN |
2002 |
|
RU2350622C2 |
CyaA-CARRIED POLYPEPTIDE (VERSIONS) AND USE TO INDUCE BOTH THERAPEUTIC AND PROPHYLACTIC IMMUNE RESPONSES |
2012 |
- Eskerr Mishel
- Momo Mari
- Guber Ann
- Misseri Jolanda
|
RU2668795C2 |
ANTIGEN MATRIX FOR TREATMENT OF BONE DISEASE |
2002 |
- Bakhmann Martin
- Maurer Patrik
- Shpon Gjunter
|
RU2322258C2 |